|Articles|May 18, 2016
CDISC and TransCelerate Announce New Standard for Breast Cancer
CDISC and TransCelerate announce new Therapuetic Area Standard for Breast Cancer, which allows for data to be shared among industry professionals.
Advertisement
CDISC and TransCelerate announce the availability of a new CDISC Therapeutic Area Standard for Breast Cancer. This standard has the ability to streamline the way clinical research is conducted so that data can be shared among clinicians, researchers and regulators worldwide. Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Nipocalimab Delivers Positive Phase IIb Results in JASMINE SLE Trial
2
Fresh Starts, Real Readiness: Turning Site Initiation into a Trial Success Multiplier
3
ACT Brief: Rethinking Representation in Cancer Trials, Positive Phase IIb SLE Data, and a Major Obesity Drug Partnership
4
ACT Brief: Reframing Site Initiation Readiness, Operational Execution as Competitive Advantage, and a Historic Motion Sickness Approval
5